Literature DB >> 15784526

Methadone maintenance and male sexual dysfunction.

Randy Brown1, Stacey Balousek, Marlon Mundt, Michael Fleming.   

Abstract

PURPOSE: This study reports the prevalence and types of sexual dysfunction in a sample of men on methadone maintenance for opioid dependence, and describes factors which may contribute to sexual dysfunction.
METHODS: 92 opioid-dependent men were recruited from a methadone maintenance clinic and completed two questionnaires, a research interview and laboratory measures.
RESULTS: Fourteen percent reported some sexual dysfunction. Erectile dysfunction (r = 0.24, p = 0.020), libido dysfunction (r = 0.30, p = 0.003), and global dysfunction (r = 0.26, p = 0.013) increased with increasing age of the patient. Methadone dose showed a significant direct correlation with increased orgasm dysfunction, both before and after adjusting for duration of treatment (p = 0.012). None of the sexual dysfunction subscales or global dysfunction were associated with plasma testosterone or plasma prolactin levels.
CONCLUSIONS: The rate of global sexual dysfunction in methadonetreated men is similar to general population studies and should be evaluated using general population guidelines. Orgasm dysfunction is a special case and may respond to methadone dose reduction.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15784526     DOI: 10.1300/J069v24n02_08

Source DB:  PubMed          Journal:  J Addict Dis        ISSN: 1055-0887


  25 in total

1.  Erectile dysfunction in opioid users: lack of association with serum testosterone.

Authors:  Patricia A Cioe; Peter D Friedmann; Michael D Stein
Journal:  J Addict Dis       Date:  2010-10

2.  [Adverse side-effect on sexual function caused by psychotropic drugs and psychotropic substances].

Authors:  S Cohen; K U Kühn; B Sträter; N Scherbaum; W Weig
Journal:  Nervenarzt       Date:  2010-09       Impact factor: 1.214

3.  Androgen levels in older men who have or who are at risk of acquiring HIV infection.

Authors:  Robert S Klein; Yungtai Lo; Nanette Santoro; Adrian S Dobs
Journal:  Clin Infect Dis       Date:  2005-11-11       Impact factor: 9.079

4.  Sexual HIV risk behaviors in a treatment-refractory opioid-dependent sample.

Authors:  R Kathryn McHugh; Meara Weitzman; Steven A Safren; Heather W Murray; Mark H Pollack; Michael W Otto
Journal:  J Psychoactive Drugs       Date:  2012 Jul-Aug

Review 5.  Clinical factors associated with sexual dysfunction among men in methadone maintenance treatment and buprenorphine maintenance treatment: a meta-analysis study.

Authors:  A Yee; H S Loh; H M B Hisham Hashim; C G Ng
Journal:  Int J Impot Res       Date:  2014-07-03       Impact factor: 2.896

6.  Change in symptoms of erectile dysfunction in depressed men initiating buprenorphine therapy.

Authors:  Patricia A Cioe; Bradley J Anderson; Michael D Stein
Journal:  J Subst Abuse Treat       Date:  2013-07-23

7.  A systematic review of the correlates and management of nonpremature ejaculatory dysfunction in heterosexual men.

Authors:  Raouf Seyam
Journal:  Ther Adv Urol       Date:  2013-10

8.  The effects of opioid-agonist treatments on HIV risk and social stability: A mixed methods study of women with opioid use disorder in Ukraine.

Authors:  Emily Hoff; Ruthanne Marcus; Martha J Bojko; Iuliia Makarenko; Alyona Mazhnaya; Frederick L Altice; Jaimie P Meyer
Journal:  J Subst Abuse Treat       Date:  2017-10-12

9.  Treatments of Sexual Dysfunction in Opioid Substitution Therapy Patients: A Systematic Review and Meta-Analysis.

Authors:  Fitri Fareez Ramli; Muhammad Hasif Azizi; Syed Alhafiz Syed Hashim
Journal:  Int J Med Sci       Date:  2021-04-12       Impact factor: 3.738

10.  Sexual dysfunction improved in heroin-dependent men after methadone maintenance treatment in Tianjin, China.

Authors:  Minying Zhang; Huifang Zhang; Cynthia X Shi; Jennifer M McGoogan; Baohua Zhang; Linglong Zhao; Mianzhi Zhang; Keming Rou; Zunyou Wu
Journal:  PLoS One       Date:  2014-02-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.